
CMS pitched a $90 billion fraud crackdown. Nearly all of it is insurer clawbacks
The money would come from audits of Medicare Advantage insurers, scaled up from samples. Without that step, CMS estimates the audits would recover $44.8 million a year. Its last rule doing it was vacated in Humana's lawsuit.
KeyVex News··6 min readFact-checked against 6 public records
KeyVex News··6 min readFact-checked against 6 public records
UNH$389.68▼ 5.4%Close, Nov. 17. Prices from Tiingo.The short versionTap to readTap to close
- CMS pitched CRUSH as a crackdown on fraud, like bills for wheelchairs nobody got. Its own table counts $90.17 billion of the rule's $90.23 billion from one item: overpayments clawed back from Medicare Advantage insurers.
- The audits check a sample of patient records. CMS wants to apply each sample's error rate to the whole contract. Without that, CMS estimates they recover $44.8 million a year and cost about $48 million.
- So nearly all of the $90 billion depends on CMS being allowed to extrapolate. Humana sued over CMS's 2023 version and won in September 2025, on procedural grounds. The government's appeal is pending.
- Comments on CRUSH close Jan. 19, 2027, CMS said. Nothing in it takes effect until CMS issues a final rule.
The selloff: UnitedHealth Group fell 5.4% on Nov. 17, to $389.68, the day after the Centers for Medicare & Medicaid Services proposed a rule it calls CRUSH.KeyVexCMS release Humana fell 3.9%, while the S&P 500, measured by the SPY fund, fell 1%.KeyVex On Nov. 18, both were down another 11% to 12% as of 2:33 p.m. ET, KeyVex's intraday quotes show.KeyVex Neither the rule nor the prices say why the stocks moved.
The pitch: CMS said the proposal "could save taxpayers nearly $90 billion over the next 10 years."CMS release Its release spoke of criminals billing Medicare for canes and wheelchairs nobody got, and of people signed up for coverage without their consent.CMS release "Every taxpayer dollar lost to fraud is a dollar that cannot support the care these programs were created to provide," CMS Administrator Dr. Mehmet Oz said.CMS release The release lists the insurer audits first among the rule's Medicare provisions, without saying how much of the $90 billion they account for.CMS release
The math: The rule's own cost table tells a narrower story. It counts $90.23 billion moving to the government over ten years, and $90.17 billion of it comes from one provision: audits that claw back overpayments from Medicare Advantage insurers, the private companies that offer Medicare coverage under contract.CMS proposed rule Nearly all of that depends on one step, extrapolation. Without it, CMS estimates the audits would recover $44.8 million a year and cost about $48 million.CMS proposed rule CMS's last rule with that step, from 2023, was vacated in Humana's lawsuit on procedural grounds, and the government has appealed.Humana 10-Q
UnitedHealth's stock since January 2023Daily close, Jan. 3, 2023 to Nov. 17, 2026 ▼ 24.9%Show chartHide chart
Where the $90 billion comes from
Medicare pays Medicare Advantage insurers more for sicker patients, based on the diagnoses the insurers report.CMS proposed rule CMS checks those diagnoses afterward with risk adjustment data validation audits, known as RADV, which compare them with patients' medical records.CMS proposed rule The rule says Medicare Advantage overpayments from inflated risk scores run about $21 billion a year.CMS proposed rule
CRUSH would let CMS take the error rate it finds in a sample of patients and apply it to the whole contract under audit, starting with payment year 2018.CMS proposed ruleCMS fact sheet An insurer's contract is its plan agreement with CMS. CRUSH would also make insurers repay what the audits find.CMS proposed rule And it would skip a "fee-for-service adjuster," a cut to the amount recovered that CMS planned in 2012 and later dropped, and that Humana says CMS should apply.CMS proposed ruleCMS fact sheetHumana 10-Q
CMS estimates that brings in about $9 billion per payment year.CMS fact sheet Over 2027 to 2036, the rule's table counts $90.17 billion from these audits, out of $90.23 billion in transfers for the whole rule.CMS proposed rule The table's other transfer lines, all Medicaid items, net to about $63 million, by KeyVex's math.CMS proposed rule CMS put no dollar figure on several of the fraud provisions, saying it "cannot estimate" their savings, and its actuaries have not yet scored the rule.CMS proposed rule
View the data
| Year | Money CMS expects back from Medicare Advantage insurers through audits | Note |
|---|---|---|
| 2027 | $2.2B | |
| 2028 | $16.8B | |
| 2029 | $16.8B | |
| 2030 | $13.6B | |
| 2031 | $6.8B | |
| 2032 | $6.8B | |
| 2033 | $6.8B | |
| 2034 | $6.8B | |
| 2035 | $6.8B | |
| 2036 | $6.8B |
Source: CMS proposed rule CMS-6098-P, Table C-B8 (transfers, MA RADV line).CMS proposed rule
How a sample becomes billions
CMS built its estimate from old audits. Audits of payment years 2011 to 2015 found $37.6 million of improper payments across 29,900 sampled patients, or $1,258 each, the rule says. It says those improper payments came from "human coding errors."CMS proposed rule CMS then applied that $1,258 to each of about 71.7 million enrollees in the 8,260 contracts it expects to audit over ten years. That multiplication is the $90.2 billion.CMS proposed rule
The rule also says what happens without that step. If CMS collected only on the sampled patients, it would recover "approximately $89.7 billion less" over the ten years, leaving about $44.8 million a year.CMS proposed rule The audit program would cost about $48 million a year, so it would lose about $3.2 million a year, CMS wrote.CMS proposed rule
CMS's audit estimates, with and without extrapolation, a yearShow chartHide chart
View the data
| CMS's estimate | Dollars a year | Note |
|---|---|---|
| With extrapolation (CMS's estimate, a year) | $9.2B | Approximately $9.2 billion a year, 2027 to 2036, the rule's impact analysis |
| Without extrapolation (CMS's estimate, a year) | $44.8M | $44.8 million a year, the rule's alternatives section |
| Cost of the audit program (CMS's estimate, a year) | $48.0M | Approximately $48 million a year, the rule's impact analysis |
Source: CMS proposed rule CMS-6098-P, regulatory impact analysis and alternatives considered.CMS proposed rule
The court fight
CMS tried this before. Its 2023 final rule also extrapolated audits from payment year 2018 without the adjuster, Humana's Nov. 6 quarterly report says.Humana 10-Q Humana sued in federal court in Fort Worth, Texas, in September 2023.Humana 10-Q
On Sept. 25, 2025, the court vacated that rule as "procedurally invalid," Humana says. The final rule was not a "logical outgrowth" of CMS's 2018 proposal.Humana 10-Q The government appealed on Nov. 21, 2025, and the case is pending at the Fifth Circuit, which hears federal appeals from Texas, as Humana v. Kennedy.Humana 10-QCMS proposed rule CRUSH proposes to reissue the provisions, the rule says, because the court vacated similar ones "for procedural reasons."CMS proposed rule
The two sides disagree on more than procedure. Humana says the 2023 rule "fails to address adequately the statutory requirement of actuarial equivalence and violates the Administrative Procedure Act."Humana 10-Q CMS's answer, in CRUSH: "MA organizations have never been entitled to receive or retain payments associated with HCCs that cannot be validated by medical records." HCCs are the diagnosis groups that set the payments.CMS proposed rule CMS also says courts have upheld sampling and extrapolation as a way to calculate improper Medicare payments, and that it first announced plans to extrapolate these audits in 2010.CMS proposed rule
Oppenheimer analysts argued the rule could meet the same fate in court as the earlier one, TipRanks reported.TipRanks
What the stocks did at the last turns
The day after CMS released the 2023 rule, UnitedHealth closed up 2.8% and Humana up 5.5%, while SPY rose 1.5%.KeyVexHumana 10-Q On Sept. 25, 2025, the day the court ruled, UnitedHealth closed down 1.8% and Humana down 2.9%, and SPY fell 0.5%.KeyVexHumana 10-Q
On Jan. 26, 2026, CMS proposed a 0.09% average increase in Medicare Advantage payments for 2027, or 2.54% counting expected risk-score trends.CMS fact sheet The next day UnitedHealth, which also reported quarterly results that day, fell 19.6%, and Humana fell 21.1%.UnitedHealth 8-KKeyVex
What happens next
CRUSH is a proposal. Nothing in it takes effect until CMS issues a final rule.CMS proposed rule If a court finds the look-back impermissibly retroactive, CMS says the rule should still apply to payment years that have not yet occurred.CMS proposed rule Until the courts and CMS settle it, the $90 billion rests on whether CMS may extrapolate.CMS proposed rule
What to watch
CRUSH's scheduled publication date in the Federal Register.CMS proposed rule
Comments on CRUSH are due, CMS said.CMS release
The Fifth Circuit appeal of the 2025 ruling, Humana v. Kennedy.Humana 10-Q
The paper trail
The records cited here, January 2026 to November 2026.
| Filed (ET) | Form | Filer | What it shows |
|---|---|---|---|
| Nov. 16, 2026 | Proposed rule | CMS | CRUSH, CMS-6098-P: extrapolated Medicare Advantage audits from payment year 2018; $90.17 billion of $90.23 billion in ten-year transfers. |
| Nov. 16, 2026 | Release | CMS | "Nearly $90 billion" over ten years; comments due Jan. 19, 2027. |
| Nov. 6, 2026 | 10-Q | Humana | RADV audits; the 2025 ruling vacating the 2023 rule; appeal pending at the Fifth Circuit. |
| Jan. 26, 2026 | Fact sheet | CMS | 2027 Advance Notice: 0.09% average Medicare Advantage payment increase. |
Related coverage
Sources
8 sources, 6 of them public records
Public records
- CMS, Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH), proposed rule CMS-6098-P (Federal Register public inspection 2026-23461)Federal Register · Nov. 2026
- CMS, "CMS CRUSH Proposed Rule Aims to Reap Nearly $90 Billion for Taxpayers in Savings by Targeting Fraud Across Medicare, Medicaid/CHIP, and the Marketplace"CMS · Nov. 16, 2026
- CMS fact sheet, CRUSH Proposed Rule (CMS-6098-P)CMS · Nov. 16, 2026
- Humana Inc., quarterly report for the period ended Sept. 30, 2026 (Form 10-Q)SEC EDGAR · Nov. 6, 2026
- UnitedHealth Group, fourth quarter and full year 2025 results (Form 8-K, Item 2.02)SEC EDGAR · Jan. 27, 2026
- CMS fact sheet, 2027 Medicare Advantage and Part D Advance NoticeCMS · Jan. 26, 2026
Reporting
- "Healthcare Stocks UnitedHealth (UNH), Humana (HUM), Cigna (CI) and Others Fall on Proposed CRUSH Rule"TipRanks · Nov. 18, 2026
Data
- Daily prices for UNH, HUM and SPY, and Nov. 18 intraday quotes (Tiingo)KeyVex · through Nov. 18, 2026
How we got these numbers
- The transfer figures are from Table C-B8 of the proposed rule (in millions): MA RADV, (90,166.10) over 2027 to 2036, by year 2,201.80; 16,804.20; 16,813.60; 13,586.70; then 6,793.30 a year for 2031 to 2036. Total transfers for the rule, (90,228.76). "About $63 million" for the rest of the rule is KeyVex's math: 90,228.76 less 90,166.10 is 62.66. The rule's text rounds the audit figure to $90.2 billion and the annualized transfer to approximately $9.2 billion; its fact sheet says an average of approximately $9 billion per payment year. Without extrapolation, the rule says recoveries would be approximately $89.7 billion less over 2027 to 2036, with annualized non-extrapolated recoveries of $44.8 million against an annualized program cost of approximately $48 million, a negative return of approximately $3.2 million a year. The $1,258 per sampled patient is CMS's ($37.6 million divided by 29,900 sampled enrollees, payment years 2011 to 2015); 8,260 contracts and about 71.7 million sampling-frame enrollees are CMS's ten-year assumptions.
- Stock moves use closes as traded from Tiingo via KeyVex. Nov. 16 to Nov. 17, 2026: UnitedHealth $412.02 to $389.68 (-5.4%); Humana $461.25 to $443.34 (-3.9%); SPY $739.95 to $732.44 (-1.0%). Jan. 30 to Jan. 31, 2023: UnitedHealth $485.79 to $499.19 (+2.8%); Humana $484.91 to $511.70 (+5.5%); SPY $400.59 to $406.48 (+1.5%). Sept. 24 to Sept. 25, 2025: UnitedHealth $351.81 to $345.56 (-1.8%); Humana $261.97 to $254.43 (-2.9%); SPY $661.10 to $658.05 (-0.5%). Jan. 26 to Jan. 27, 2026: UnitedHealth $351.64 to $282.70 (-19.6%); Humana $263.63 to $207.93 (-21.1%). Nov. 18 moves are intraday, not closes: KeyVex's Tiingo IEX quotes at 2:33 p.m. ET, UnitedHealth $345.33 (-11.4% from $389.68) and Humana $391.57 (-11.7% from $443.34); KeyVex had no Nov. 18 close when this was written. UnitedHealth also reported its fourth-quarter 2025 results on Jan. 27, 2026 (Form 8-K). The dates are given without a cause: the records do not say why a stock moved.
- The court facts (filing in September 2023, the Sept. 25, 2025 ruling, the Nov. 21, 2025 notice of appeal and the case name Humana v. Kennedy) are from Humana's Form 10-Q for the quarter ended Sept. 30, 2026; the proposed rule cites the same case and appeal. The 2023 rule's release date, Jan. 30, 2023, is from Humana's 10-Q; the rule says it was published in the Federal Register on Feb. 1, 2023. The Oppenheimer view is as TipRanks reported it; TipRanks did not name an analyst. The chart's comparison lines follow SPY (S&P 500) and QQQ (Nasdaq 100), rebased. The Filings switch shows the filing markers from KeyVex's UnitedHealth stock page, a selection of congressional trades, insider sales, Form 144 notices, 8-Ks and lobbying filings: not every filing, and not only those tied to this story. The header image was generated for KeyVex by an image model. It is an illustration of a medical records room, not a photograph of CMS, an insurer or a real audit. This is a reading of a proposed rule, company filings, prices and news reports, not investment advice.







